| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A patient with B-cell acute lymphoblastic leukemia with PAX5-ETV6 rearrangement with dic(9;12)(p13;p13) identified by chromosomal microarray
|
Ha, Jihye
|
|
2018
|
97 |
8 |
p. 1505-1507
|
article
|
| 2 |
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes
|
Montoro, Julia
|
|
2018
|
97 |
8 |
p. 1349-1356
|
article
|
| 3 |
BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
|
Zhang, Jilei
|
|
2018
|
97 |
8 |
p. 1391-1397
|
article
|
| 4 |
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia
|
Paludo, Jonas
|
|
2018
|
97 |
8 |
p. 1417-1425
|
article
|
| 5 |
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
|
Hong, Jung Yong
|
|
2018
|
97 |
8 |
p. 1437-1443
|
article
|
| 6 |
Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma
|
Nakazato, Tomonori
|
|
2018
|
97 |
8 |
p. 1489-1491
|
article
|
| 7 |
Clinical impact of underweight status at diagnosis on elderly patients with acute myeloid leukemia: a retrospective study of JALSG GML200
|
Harada, Kaito
|
|
2018
|
97 |
8 |
p. 1481-1483
|
article
|
| 8 |
Comorbidities, repeated hospitalizations, and age ≥ 80 years as indicators of anemia development in the older population
|
Michalak, Sylwia Sulimiera
|
|
2018
|
97 |
8 |
p. 1337-1347
|
article
|
| 9 |
Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae
|
Marks, Reinhard
|
|
2018
|
97 |
8 |
p. 1497-1500
|
article
|
| 10 |
Eculizumab treatment for ischemic enteritis accompanied with paroxysmal nocturnal hemoglobinuria: a case report and literature review
|
Yasunaga, Megumi
|
|
2018
|
97 |
8 |
p. 1513-1515
|
article
|
| 11 |
Efficacy and safety of decitabine against cutaneous granuloblastic sarcoma: a case report
|
Castelli, Andrea
|
|
2018
|
97 |
8 |
p. 1485-1486
|
article
|
| 12 |
Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin’s lymphomas: evidence from a meta-analysis
|
Huang, Yi-shu
|
|
2018
|
97 |
8 |
p. 1317-1325
|
article
|
| 13 |
Eltrombopag as initial monotherapy for severe aplastic anemia—a case report
|
Rodgers, George M.
|
|
2018
|
97 |
8 |
p. 1517-1518
|
article
|
| 14 |
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients
|
González-Calle, Verónica
|
|
2018
|
97 |
8 |
p. 1453-1462
|
article
|
| 15 |
IgG synthesis rate and anti-myelin oligodendrocyte glycoprotein antibody in CSF may be associated with the onset of CNS demyelination after haplo-HSCT
|
Zhang, Xiao-hui
|
|
2018
|
97 |
8 |
p. 1399-1406
|
article
|
| 16 |
Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
|
Yamasaki, Satoshi
|
|
2018
|
97 |
8 |
p. 1445-1452
|
article
|
| 17 |
Isolated Richter’s syndrome of the brain: diagnosis in the eye of the beholder
|
Pinto, Ana Luísa
|
|
2018
|
97 |
8 |
p. 1509-1511
|
article
|
| 18 |
Large granular lymphocytic leukemia-associated peripheral neuropathy
|
Saini, Neeraj Y
|
|
2018
|
97 |
8 |
p. 1501-1504
|
article
|
| 19 |
Late-onset hemophagocytic lymphohistiocytosis with varicella zoster virus and Epstein-Barr virus co-infection after umbilical cord blood transplantation
|
Ono, Koya
|
|
2018
|
97 |
8 |
p. 1493-1495
|
article
|
| 20 |
Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis
|
Pelzer, Benedikt W.
|
|
2018
|
97 |
8 |
p. 1463-1469
|
article
|
| 21 |
Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia
|
Wang, Xinfeng
|
|
2018
|
97 |
8 |
p. 1375-1389
|
article
|
| 22 |
Major response of PNH to an AML chemotherapy protocol
|
Füreder, Wolfgang
|
|
2018
|
97 |
8 |
p. 1487-1488
|
article
|
| 23 |
Necrobiotic xanthogranuloma: a 30-year single-center experience
|
Hilal, Talal
|
|
2018
|
97 |
8 |
p. 1471-1479
|
article
|
| 24 |
Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study
|
Mascarenhas, J.
|
|
2018
|
97 |
8 |
p. 1369-1374
|
article
|
| 25 |
Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study
|
Kim, Dong-Wook
|
|
2018
|
97 |
8 |
p. 1357-1367
|
article
|
| 26 |
Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma
|
Cho, Jinhyun
|
|
2018
|
97 |
8 |
p. 1427-1436
|
article
|
| 27 |
Temporal trajectory of quality of life and its predictors in recipients of hematopoietic stem cell transplantation
|
Kim, Ryul
|
|
2018
|
97 |
8 |
p. 1407-1415
|
article
|
| 28 |
The severe cytokine release syndrome in phase I trials of CD19-CAR-T cell therapy: a systematic review
|
Jin, Zhen
|
|
2018
|
97 |
8 |
p. 1327-1335
|
article
|
| 29 |
Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors
|
Carella, A. M.
|
|
2018
|
97 |
8 |
p. 1301-1315
|
article
|
Journal description